Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03874988 · ClinicalTrials.gov registry record · NA
Building an Evidence Base for Weight Loss Strategies Among Those With Chronic SCI-The GLB-SCI+
A NA study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
NCT03874988: Completed NA study, sponsored by Baylor Research Institute.
NCT03874988 is a NA study that has completed, run by Baylor Research Institute. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03874988, a NA study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
Study Summary
This study's overarching aim is to follow a systematic approach that incorporates community-based participatory research (CBPR) to develop a multi-component weight loss intervention that may yield significant effects for a chronic SCI sample. The approach is to obtain data on the 3 unique strategies (prepackaged/portion-controlled meals; enhanced self-monitoring; the GLB-SCI) to inform design of an empirically supported and consumer-validated multicomponent intervention program, that combines the best of the 3 approaches into one unique intervention, the GLB SCI+. Based on the investigators' prior experience with adapting and delivering the GLB AIM (a lifestyle intervention previously adapted for those with impaired mobility), interim findings, existing literature, and consumer feedback, they hypothesize that these 3 unique strategies may confer individualized benefits to people with SCI given their complex disability-related barriers to weight loss.
Primary Outcome
Change in weight (pounds) will be measured after each 13-week intervention.
Interventions
- BEHAVIORAL Portion-Controlled Meals
- BEHAVIORAL Enhanced Self-Monitoring
- BEHAVIORAL GLB-SCI
- BEHAVIORAL GLB-SCI+
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2022-06-15 |
| Phase | NA |
What the finished NCT03874988 record still lists
NCT03874988 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 4 interventions - of which Portion-Controlled Meals is the first listed.
NCT03874988 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03874988 about?
NCT03874988 is a clinical study titled "Building an Evidence Base for Weight Loss Strategies Among Those With Chronic SCI-The GLB-SCI+". This study's overarching aim is to follow a systematic approach that incorporates community-based participatory research (CBPR) to develop a multi-component weight loss intervention that may yield significant effects for a chronic SCI sample. The approach is to obtain data on the 3 unique strategies...
What is the current status of trial NCT03874988?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2019-06-01. Estimated completion is 2022-06-15.
What interventions are being tested in trial NCT03874988?
The interventions under investigation include: Portion-Controlled Meals (BEHAVIORAL), Enhanced Self-Monitoring (BEHAVIORAL), GLB-SCI (BEHAVIORAL), GLB-SCI+ (BEHAVIORAL).
Who is sponsoring clinical trial NCT03874988?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03874988's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI